Arnav Mehta

Arnav Mehta

Harvard University

H-index: 27

North America-United States

About Arnav Mehta

Arnav Mehta, With an exceptional h-index of 27 and a recent h-index of 26 (since 2020), a distinguished researcher at Harvard University, specializes in the field of cancer, immunology, single-cell and spatial genomics, computational biology, machine learning.

His recent articles reflect a diverse array of research interests and contributions to the field:

Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy

Abstract NG08: Dissecting and quantifying pancreatic cancer plasticity using single-cell multiomics, lineage tracing and functional genomics reveals novel mediators of therapy …

Understanding spatial organization of cellular plasticity in pancreatic ductal adenocarcinoma

Understanding radiation and immunotherapy induced cell state shifts in the pancreatic tumor microenvironment

Spatial organization and cellular composition of immunity hubs in human colorectal cancer

Tumor cell metaplastic programs and failure of T cell remodeling drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade

Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy

Arnav Mehta Information

University

Position

Hematology/Oncology Fellow, Broad Institute and MGH/DFCI

Citations(all)

3702

Citations(since 2020)

3110

Cited By

1323

hIndex(all)

27

hIndex(since 2020)

26

i10Index(all)

37

i10Index(since 2020)

36

Email

University Profile Page

Google Scholar

Arnav Mehta Skills & Research Interests

cancer

immunology

single-cell and spatial genomics

computational biology

machine learning

Top articles of Arnav Mehta

Abstract NG08: Dissecting and quantifying pancreatic cancer plasticity using single-cell multiomics, lineage tracing and functional genomics reveals novel mediators of therapy …

Cancer Research

2024/4/5

Understanding spatial organization of cellular plasticity in pancreatic ductal adenocarcinoma

Cancer Research

2024/3/22

Doron Haviv
Doron Haviv

H-Index: 3

Arnav Mehta
Arnav Mehta

H-Index: 14

Understanding radiation and immunotherapy induced cell state shifts in the pancreatic tumor microenvironment

Cancer Research

2024/3/22

Spatial organization and cellular composition of immunity hubs in human colorectal cancer

Cancer Research

2024/3/22

Tumor cell metaplastic programs and failure of T cell remodeling drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer

Cancer Research

2024/3/22

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade

bioRxiv

2022/2/5

Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

Cancer Discovery

2024/2/27

Association of Somatic TET2 Mutations With Giant Cell Arteritis

Arthritis & Rheumatology

2024/2/2

Lineage Plasticity: The New Cancer Hallmark on the Block

2024/1/16

Arnav Mehta
Arnav Mehta

H-Index: 14

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Nature Medicine

2023/2

655 Dissecting pancreatic cancer tumor-immune microenvironment crosstalk using spatial transcriptomics

2023/11/1

Somatic TET2 mutations are associated with giant cell arteritis

medRxiv

2023

152 Immuno-oncology protein biomarker panels provide greater biological insights and improved patient stratification

2023/11/1

Arnav Mehta
Arnav Mehta

H-Index: 14

Ryan Sullivan
Ryan Sullivan

H-Index: 7

628 Circulatory plasma proteomic biomarkers combined with high-throughput proteomic screen of patient-derived organotypic tumor spheroids predict responses to immunotherapy in …

2023/11/1

561 Targeting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy

2023/11/1

Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune …

International Journal of Radiation Oncology* Biology* Physics

2023/10/1

A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable colorectal cancer.

2023/6/1

Arnav Mehta
Arnav Mehta

H-Index: 14

Aparna Raj Parikh
Aparna Raj Parikh

H-Index: 15

Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor immune microenvironment in advanced gastric cancer: a phase II chemoimmunotherapy trial

2023/5/31

See List of Professors in Arnav Mehta University(Harvard University)

Co-Authors

academic-engine